Entering text into the input field will update the search result below

ReShape Q3 top line down 3%; shares up 4% after hours

Nov. 14, 2018 4:39 PM ETReShape Lifesciences Inc. (RSLS) StockRSLSBy: Douglas W. House, SA News Editor
  • ReShape Lifesciences (OTC:RSLS) Q3 results ($M): Revenue: 0.4 (-2.7%); net loss: (7.0) (+30.0%); cash and equivalents: 0.5 (-95.1%).
  • European study initiated in Europe to support CE Mark certification of ReShape Vest.
  • Retired all Series D convertible preferred shares.
  • Shares are up 4% after hours.
  • Previously: ReShape Lifesciences EPS of -$27.46 (Nov. 14)

Recommended For You

More Trending News

About RSLS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
RSLS--
ReShape Lifesciences Inc.